ClassActionLawsuits.biz

You are browsing the archives of 2008 November.

Medtronic Inc. issued an alert to doctors on February 10, 2005, regarding its product line of Implantable Cardioverter Defibrillators (ICD) and CRT-D devices with batteries that were manufactured before December 2003. The ICD is a pacemaker-like device that is surgically implanted in patients who suffer from irregular heartbeat.  Unfortunately, it has been found that some [...]

Zyprexa, an antipsychotic drug also known as Olanzapine, normally prescribed for the treatment of schizophrenia and bipolar mania, has been linked to serious side effects including diabetes, hyperglycemia, pancreatitis, ketoacidosis, and diabetic coma.  To this point there have been 288 reported diabetes cases in Zyprexa patients, with 23 of them being fatal.
The drug has been [...]

Vioxx, the trade name of the generic drug rofecoxib, was approved by the U.S. Food and Drug Administration (FDA) in May 1999, for the treatment of osteoarthritis, menstrual pain and the management of acute pain in adults. On September 30, 2004 the manufacturer of Vioxx, Merck & Co., Inc. (Merck) announced that it was voluntarily [...]

December 19, 2002 — James J. McMonagle, Claims Administrator to the Sulzer Settlement Trust, announced today that the Trust is issuing payments totaling over $285,000,000 to approximately 5,500 claimants who have filed Claims arising from the implantation of certain hip and knee replacement joints manufactured by United States subsidiaries of Swiss medical device manufacturer, Sulzer [...]

Serzone, by Bristol-Myers Squibb Co. is a drug that is used by some physicians to treat depression. Serzone, also known as nefazodone hydrochloride, was put on the U.S. market with no warnings whatsoever regarding potential liver damage even though pre-clinical trials showed that there was the possibility of liver damage to humans. After Serzone was [...]

The Kahn Gauthier Law Group is investigating any possible lawsuit against drug manufacturer Pfizer to recover for injuries suffered by users of the now-withdrawn diabetes medication Rezulin (troglitazone). Rezulin was prescribed for type 2, or non-insulin dependent, diabetes patients who had not responded to other therapies. This type of diabetes typically is found in adults.
Rezulin [...]

On March 23, 2000, the US Food and Drug Administration (FDA) announced that Janssen Pharmaceutica
(a wholly-owned subsidiary of Johnson & Johnson) would cease marketing of cisapride (Propulsid) in the United States as of July 14, 2000. In its announcement, the FDA stated that as of December 31, 1999, use of cisapride has been associated with [...]

The Kahn Gauthier Law Group has commenced an investigation into any possible lawsuit against the manufacturers of Prempro. Federal investigators have made the startling announcement that Wyeth’s drug Prempro, an estrogen-progestin combination that millions of American women take to ease the symptoms of menopause, increases the risk of several serious ailments, including heart attack, stroke, [...]

The FDA has issued a public health advisory concerning phenylpropanolamine hydrochloride. This drug is an ingredient used in many over-the-counter and prescription cough and cold medications as a decongestant as well as weight loss products.
Studies have reported that taking PPA increases the risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the [...]

On September 27, 2005, the FDA released an alert to healthcare professionals and consumers as GlaxoSmithKline changed the warning label on Paxil (also known as paroxetine) to include the risk of birth defects. The results of a recent study suggests an increased risk of babies born with birth defects, specifically cardiovascular defects or congenital malformations, [...]